Accuray Inc
ARAY Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 26, 2026
$0.12
KIRA · Stoqly’s AI analyst, in plain words
- Accuray Inc had $402M of revenue in fiscal 2026, down 12.3% on the year before. Over five years, revenue changed +0.3% a year on average.
- Its operating margin was −6.6%, down 8.3 pts: of every 100 in sales, about −7 is left after running the business.
- Accuray Inc lost $49.2M in fiscal 2026.
- Free cash flow was −$12.8M in fiscal 2026, −3.2% of revenue.
- Accuray Inc owes $107M more than it holds in cash.
Market cap
—
P/E
—
Revenue
$402M
Net income
−$49.2M
Free cash flow
−$12.8M
Operating margin
−6.6%
Accuray Inc in 30 seconds · fiscal 2026
Are sales growing?
−12.3%
No. Sales fell 12.3% last year.
Does it make a profit?
−12.2%
No. It lost money last year.
Does profit turn into cash?
−3.2%
No. It spent more cash than it brought in.
How healthy are the accounts?
1 / 8
Weak. It passes 1 of 8 health tests.
What Accuray Inc does
No business description yet.
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K · Aug 27, 2026
- Legal name
- ACCURAY INC
- CIK
- 0001138723
Accuray Inc · ARAY
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $430M | $448M | $447M | $459M | $402M |
| Revenue growth | 8.5% | 4.1% | −0.2% | 2.7% | −12.3% |
| Gross margin | 37.2% | 34.4% | 32.0% | 32.1% | 27.7% |
| Operating margin | 1.9% | 0.5% | 0.1% | 1.7% | −6.6% |
| Net income | −$5.3M | −$9.3M | −$15.5M | −$1.6M | −$49.2M |
| Net margin | −1.2% | −2.1% | −3.5% | −0.3% | −12.2% |
| Diluted EPS | −$0.06 | −$0.10 | −$0.16 | −$0.02 | — |
| Cash | |||||
| Cash from operations | −$2.4M | $15.5M | −$11.9M | $2.9M | −$7.0M |
| Capital expenditure | $4.7M | $12.6M | $3.6M | $4.3M | $5.9M |
| Free cash flow | −$7.1M | $2.9M | −$15.5M | −$1.4M | −$12.8M |
| FCF margin | −1.7% | 0.7% | −3.5% | −0.3% | −3.2% |
| Share buybacks | $0.0M | $0.0M | — | — | — |
| Share count change | 0.1% | 3.0% | 3.6% | 4.6% | — |
| Debt and strength | |||||
| Cash and short-term investments | $88.7M | $89.4M | $68.6M | $57.4M | $40.6M |
| Debt incl. finance leases | $189M | $183M | $180M | $149M | $148M |
| Shareholders' equity | $53.2M | $53.7M | $45.1M | $81.2M | $41.7M |
| Net debt / EBITDA | 7.3x | 13.5x | 17.4x | 6.6x | — |
| Current ratio | 1.7x | 1.7x | 1.7x | 1.6x | 1.5x |
| Interest coverage | 1.0x | 0.2x | 0.0x | 0.6x | −0.8x |
| Returns and quality | |||||
| Return on capital | 4.2% | 1.3% | 0.3% | 2.9% | −14.0% |
| Return on equity | −8.8% | −17.4% | −31.5% | −2.5% | −80.1% |
| Return on tangible equity | — | — | — | −6.8% | — |
| Piotroski F-score | 3 | 5 | 2 | 6 | 1 |
| Altman Z'' | −1.2 | −1.3 | −1.7 | −1.5 | −3.0 |
Insiders bought, 12 months
$0.2M
2 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Accuray Inc · ARAY
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $0.12 a share, the company is worth —.
Source: SEC EDGAR XBRL filings (CIK 0001138723). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.